USP25 and Alzheimer disease: However, we further performed Spearman’s correlation analysis and found a positive correlation between the amounts of USP25 and APP/BACE1/Aβ42 in the cortices of patients with AD (Figure 8, C–E), suggesting a potential role for the USP25-mediated amyloidogenic pathway in AD pathogenesis.